| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.56B | -6.4% |
| Cost of Revenue | $245.3M | -3.0% |
| R&D Expense | $245.3M | -9.4% |
| SG&A Expense | $645.2M | -6.5% |
| Operating Income | $420.6M | +1.6% |
| Pre-tax Income | $443.8M | +5.3% |
| Income Tax | $71.6M | +173.3% |
| Net Income | $367.1M | +3.2% |
| EPS (Basic) | $2.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $291.1M | -36.4% |
| Accounts Receivable | $384.5M | +15.7% |
| Inventory | $182.9M | -1.9% |
| Current Assets | $1.42B | -4.7% |
| Total Assets | $2.06B | -3.8% |
| Current Liabilities | $465.2M | -10.6% |
| Long-term Debt | $287.7M | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $439.1M | +9.4% |
| Capital Expenditures | $33.5M | -30.3% |
| Investing Cash Flow | -$111.3M | -308.6% |
| Financing Cash Flow | -$494.1M | -70.6% |
| Free Cash Flow | $405.6M | +14.8% |
| +3.7% |
| EPS (Diluted) | $2.17 | +3.3% |
| Total Liabilities |
| $590.6M |
| -36.7% |
| Stockholders' Equity | $1.46B | +21.8% |